ArticleNutrition & diabetes2020

Novel CB1 receptor antagonist BAR-1 modifies pancreatic islet function and clinical parameters in prediabetic and diabetic mice.

Lesly Nava-Molina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.